Bharat Biotech of India, in collaboration with the Indian Council of Medical Research, has developed a vaccine, Covaxin, using an inactivated virus strain. A university in India said a Phase 3 trial of the vaccine began there in mid-November.
Jonathan D. Rockoff, Chao Deng, Raffaele Huang, Yan Wu, Georgi Kantchev, Jared S. Hopkins and Dasl Yoon contributed to this article.
Write to Ana Rivas at firstname.lastname@example.org, Peter Loftus at email@example.com and Alberto Cervantes at Alberto.Cervantes@wsj.com
(END) Dow Jones Newswires